ArticlePoultry science2026
ANKRD9 negatively regulates chicken myogenesis through ubiquitin-mediated regulation of IMPDH2.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skeletal muscle development is regulated by transcriptional and post-translational mechanisms. While ankyrin repeat proteins participate in post-translational modifications, their role in myogenesis remains unclear. This study identifies ankyrin repeat domain-containing protein 9 (ANKRD9) as a novel negative regulator of chicken skeletal muscle development. ANKRD9 showed dynamic expression during postnatal muscle growth and downregulated cell cycle and DNA replication-related genes. Functionally, ANKRD9 overexpression inhibited myoblast proliferation and differentiation, while its knockdown enhanced these processes. In vivo, siRNA-mediated knockdown of ANKRD9 markedly increased muscle mass and myofiber diameter in chicks. Mechanistically, ANKRD9 bound directly to inosine monophosphate dehydrogenase 2 (IMPDH2), a rate-limiting enzyme in purine synthesis, and promoted its ubiquitin-mediated degradation without affecting mRNA levels. Crucially, rescue experiments confirmed that restoring IMPDH2 expression effectively reversed the inhibitory effects of ANKRD9 on myoblast proliferation and differentiation. Thus, this study unveils a novel regulatory axis in which ANKRD9 negatively regulates skeletal myogenesis by mediating the ubiquitination of IMPDH2. This discovery not only provides new insights into the post-translational regulatory network governing muscle development but also offers a potential target for genetic improvement of meat yield in poultry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.